Related references
Note: Only part of the references are listed.Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression When Enough Is Enough
Charles R. Conway et al.
JAMA PSYCHIATRY (2017)
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
Jose A. Morales-Garcia et al.
SCIENTIFIC REPORTS (2017)
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
Joaquim Soler et al.
PSYCHOPHARMACOLOGY (2016)
Neuropharmacology of N,N-dimethyltryptamine
Theresa M. Carbonaro et al.
BRAIN RESEARCH BULLETIN (2016)
Psychological and neuropsychological assessment of regular hoasca users
Paulo Cesar Ribeiro Barbosa et al.
COMPREHENSIVE PSYCHIATRY (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Harmine stimulates proliferation of human neural progenitors
Vanja Dakic et al.
PEERJ (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Aline Pic-Taylor et al.
BEHAVIOURAL PROCESSES (2015)
Hamilton depression rating scale and montgomery-asberg depression rating scale in depressed and bipolar I patients: psychometric properties in a Brazilian sample
Adriana Munhoz Carneiro et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2015)
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Tomislav Majic et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
New hypothesis and treatment targets of depression: an integrated view of key findings
Shangli Cai et al.
NEUROSCIENCE BULLETIN (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
Draulio B. de Araujo et al.
HUMAN BRAIN MAPPING (2012)
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
Jose Carlos Bouso et al.
PLOS ONE (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca A Comparative Study With D-Amphetamine
Rafael G. dos Santos et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
Zindel V. Segal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties
Jucelia J. Fortunato et al.
BRAIN RESEARCH BULLETIN (2010)
Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
Jucelia J. Fortunato et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
The default mode network and self-referential processes in depression
Yvette I. Sheline et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Reliability and validity of a Portuguese version of the Young Mania Rating Scale
JAA Vilela et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experience
JAS Crippa et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
